The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Leif Groop

Leif Groop

Principal investigator

Leif Groop

Human pancreatic islet three-dimensional chromatin architecture provides insights into the genetics of type 2 diabetes


  • Irene Miguel-Escalada
  • Silvia Bonàs-Guarch
  • Inês Cebola
  • Joan Ponsa-Cobas
  • Julen Mendieta-Esteban
  • Goutham Atla
  • Biola M. Javierre
  • Delphine M.Y. Rolando
  • Irene Farabella
  • Claire C. Morgan
  • Javier García-Hurtado
  • Anthony Beucher
  • Ignasi Morán
  • Lorenzo Pasquali
  • Mireia Ramos-Rodríguez
  • Emil V.R. Appel
  • Allan Linneberg
  • Anette P. Gjesing
  • Daniel R. Witte
  • Oluf Pedersen
  • Niels Grarup
  • Philippe Ravassard
  • David Torrents
  • Josep M. Mercader
  • Lorenzo Piemonti
  • Thierry Berney
  • Eelco J.P. de Koning
  • Julie Kerr-Conte
  • François Pattou
  • Iryna O. Fedko
  • Leif Groop
  • Inga Prokopenko
  • Torben Hansen
  • Marc A. Marti-Renom
  • Peter Fraser
  • Jorge Ferrer

Summary, in English

Genetic studies promise to provide insight into the molecular mechanisms underlying type 2 diabetes (T2D). Variants associated with T2D are often located in tissue-specific enhancer clusters or super-enhancers. So far, such domains have been defined through clustering of enhancers in linear genome maps rather than in three-dimensional (3D) space. Furthermore, their target genes are often unknown. We have created promoter capture Hi-C maps in human pancreatic islets. This linked diabetes-associated enhancers to their target genes, often located hundreds of kilobases away. It also revealed >1,300 groups of islet enhancers, super-enhancers and active promoters that form 3D hubs, some of which show coordinated glucose-dependent activity. We demonstrate that genetic variation in hubs impacts insulin secretion heritability, and show that hub annotations can be used for polygenic scores that predict T2D risk driven by islet regulatory variants. Human islet 3D chromatin architecture, therefore, provides a framework for interpretation of T2D genome-wide association study (GWAS) signals.


  • Genomics, Diabetes and Endocrinology
  • EXODIAB: Excellence of Diabetes Research in Sweden
  • LUBIN Lab- Lund Brain Injury laboratory for Neurosurgical research

Publishing year







Nature Genetics





Document type

Journal article


Nature Publishing Group


  • Genetics
  • Endocrinology and Diabetes



Research group

  • Genomics, Diabetes and Endocrinology
  • LUBIN Lab- Lund Brain Injury laboratory for Neurosurgical research


  • ISSN: 1061-4036